Hôpital Forcilles
Férolles-Attilly, 77150, France
NCT Number: NCT05479396
The assessment of health status and physical function is fundamental in patients with obesity, as they play an important role among the various factors influencing quality of life in this population. Several studies have shown an association between high BMI values and a significant deterioration in quality of life, especially in women. Excess body fat in obese patients appears to be responsible for impaired muscle function. This causal link is probably linked to dysfunctions in adipose tissue, leading to a decrease in the expression of proteins responsible for muscle contraction. The recent literature highlights an alteration in quality of life, particularly in obese and elderly subjects, for which changes in muscle function are partly responsible.
Changes in muscle function can be assessed by simple, rapid and non-invasive tools. These changes in the obese patient could be predictive of reduced quality of life. To our knowledge, no study has evaluated the predictive capacity of muscle alteration assessed by ultrasound on the medium-term quality of life of obese patients.
The main objective of this study is to evaluate the predictive capacity of structural alteration of the quadriceps on the decrease in quality of life at 1 year in patients with obesity.
The secondary objectives are to assess the association between :
* Grip strength and quality of life at 1 year; * Quadriceps muscle strength and quality of life at 1 year; * Ultrasound measurements of the quadriceps and quality of life at 1 year; * Ultrasound measurements of the quadriceps and autonomy at 1 year; * Grip strength and autonomy at 1 year.
This is a prospective, monocenter, observationnal and cohort study.
All outpatients for nutrition assessment will be included.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Férolles-Attilly, 77150, France
1.2. Quality of life: patients with obesity with or without metabolic disorders have impaired health, including mental problems and reduced quality of life. In younger obese subjects,the investigators also observe a decrease in quality of life compared to normal weight subjects, where muscle capacity may be a potential factor associated with impaired quality of life.
1.2.1 Peripheral muscle damage: a decrease in the specific strength of the muscle, a decrease in the strength in relation to the cross-sectional area, is observed in subjects suffering from obesity. There is therefore probably a structural alteration of the muscle in the obese patient, which has not yet been described in the literature. The quantity of muscle fibres decreases and is replaced by the infiltration of adipose and fibrous tissue. This replacement of skeletal muscle fibres decreases muscle quality and increases density, thus altering its function. The reduction in muscle mass relative to fat mass, results in a relative loss of muscle strength available to support and move body weight.
1.3 Peripheral muscle ultrasound: Muscle characteristics, in particular muscle size and quality, have been shown to be related to muscle strength and power as well as cardiovascular performance. Ultrasound can also measure muscle echogenicity. The echogenicity of a B-mode (2D) ultrasound image is expressed by a grey scale. On an ultrasound image, the muscle bundles appear as hypoechoic areas, while the aponeuroses are hyperechoic. In the case of atrophied muscles, represented by hyperechoic structures, there is a decrease in the ability of ultrasound to penetrate deep into the tissue.
2 Research hypothesis The investigators hypothesise that impaired peripheral muscle function is a prognostic factor for impaired quality of life at 1 year in subjects with obesity.
3 Objective 3.1 Main objective The main objective of this study is to evaluate the predictive capacity of structural alteration of the quadriceps on the decrease in quality of life at 1 year in patients with obesity.
3.2 Secondary objectives
The secondary objectives are to assess the association between :
The tests will be performed at the 5% significance level. The 95% confidence intervals will be provided for each estimate.
Calculations will be made using IBM SPSS v21 and R software (version 3.6.1, www.R-project.org).
9 Specific analyses 9.1 Estimation of predictive capacity The occurrence of the event (alteration of quality of life at 1 year) will thus be defined for each of the summary scores (MCS and PCS) and for each of the scores of each SF-36 scale. This will allow the calculation of the AUC of the ROC curves as well as the identification of threshold values of the echogenicity of the femoral rectus allowing the prediction of the occurrence of the alteration in the quality of life.
9.2 Measurement of associations
Measures of association will be made between quality of life and quality of life impairment at 1 year and :
The association measures will be carried out between autonomy and loss of autonomy at 1 year and :
Measures of association between quantitative variables will be made using Pearson's or Spearman's correlation coefficients depending on the distribution of the data. Measures of association between qualitative variables will be performed using the Chi-square or Fisher test depending on the distribution of the data.
The agreement between quantitative variables will be evaluated using the Bland-Altman method and that between qualitative variables using the Kappa coefficient.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Through study completion, an average of 22 months
The main outcome is the predictive ability of the femoral rectus muscle echogenicity in the gray scale on the 36-Item Short Form Survey (SF-36) score at 1 year
Time frame: Through study completion, an average of 22 months
The main outcome is the association between grip strength measured by the hand-grip and the 36-Item Short Form Survey (SF-36) score at 1 year
Time frame: Through study completion, an average of 22 months
The main outcome is the association between lower limb strength measured by maximal voluntary quadriceps force dynamometry and the 36-Item Short Form Survey (SF-36) score at 1 year
Time frame: Through study completion, an average of 22 months
The main outcome is association between ultrasound measurements of the rectus femoris (thickness and mCSA) and the 36-Item Short Form Survey (SF-36) score at 1 year
Time frame: Through study completion, an average of 22 months
The main outcome is the association between grip strength measured by the hand-grip and the Katz Index of Independence in Activities of Daily Living score at 1 year.
(SCORING: 6 = High (patient independent) 0 = Low (patient very dependent)
Time frame: Through study completion, an average of 22 months
The main outcome is the association between lower limb strength measured by maximum voluntary quadriceps force with dynamometry and the Katz Index of Independence in Activities of Daily Living score at 1 year.
(SCORING: 6 = High (patient independent) 0 = Low (patient very dependent)
Time frame: Through study completion, an average of 22 months
The main outcome is the association between ultrasound measurements of the rectus femoris (thickness and mCSA) and the Katz Index of Independence in Activities of Daily Living score at 1 year.
(SCORING: 6 = High (patient independent) 0 = Low (patient very dependent)
Hopital Forcilles
Other
Study of the Predictive Capacity of Peripheral Muscle Function on Quality of Life Impairment at 1 Year in Subjects With Obesity. A Cohort Study.
Acronym: OBLITAM
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05742165
Behavior, Body Weight
New York, United States
View Trial DetailsNCT05882045
Body Weight, Cardiovascular Diseases
Phoenix, Arizona, United States
View Trial DetailsNCT05929079
Apnea, Body Weight
Anniston, Alabama, United States
View Trial DetailsNCT00342732
Body Weight, Nutrition Disorders
Phoenix, Arizona, United States
View Trial Details